U.S. flag

An official website of the United States government

NM_000535.7(PMS2):c.706-4del AND not specified

Germline classification:
Benign/Likely benign (5 submissions)
Last evaluated:
Aug 15, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000454744.12

Allele description [Variation Report for NM_000535.7(PMS2):c.706-4del]

NM_000535.7(PMS2):c.706-4del

Gene:
PMS2:PMS1 homolog 2, mismatch repair system component [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
7p22.1
Genomic location:
Preferred name:
NM_000535.7(PMS2):c.706-4del
HGVS:
  • NC_000007.13:g.6037058del
  • NC_000007.14:g.5997443del
  • NG_008466.1:g.16680del
  • NM_000535.7:c.706-4delMANE SELECT
  • NM_001322003.2:c.301-4del
  • NM_001322004.2:c.301-4del
  • NM_001322005.2:c.301-4del
  • NM_001322006.2:c.706-4del
  • NM_001322007.2:c.388-4del
  • NM_001322008.2:c.388-4del
  • NM_001322009.2:c.301-4del
  • NM_001322010.2:c.301-4del
  • NM_001322011.2:c.-228-4del
  • NM_001322012.2:c.-228-4del
  • NM_001322013.2:c.133-4del
  • NM_001322014.2:c.706-4del
  • NM_001322015.2:c.397-4del
  • LRG_161t1:c.706-4del
  • LRG_161:g.16680del
  • NC_000007.13:g.6037058del
  • NC_000007.13:g.6037058delA
  • NC_000007.13:g.6037074del
  • NM_000535.5:c.706-4del
  • NM_000535.5:c.706-4delT
  • NM_000535.5:c.706-5delT
  • NM_000535.6:c.706-4delT
  • NM_000535.6:c.706-5del
  • NM_000535.6:c.706-5delT
  • NM_000535.5:c.706-4delT
Links:
Ambry Genetics: a02961; dbSNP: rs60794673
NCBI 1000 Genomes Browser:
rs60794673
Molecular consequence:
  • NM_000535.7:c.706-4del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001322003.2:c.301-4del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001322004.2:c.301-4del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001322005.2:c.301-4del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001322006.2:c.706-4del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001322007.2:c.388-4del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001322008.2:c.388-4del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001322009.2:c.301-4del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001322010.2:c.301-4del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001322011.2:c.-228-4del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001322012.2:c.-228-4del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001322013.2:c.133-4del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001322014.2:c.706-4del - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001322015.2:c.397-4del - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000540065Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(LMM Criteria)
Benign
(Mar 28, 2016)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV001553089Department of Pathology and Laboratory Medicine, Sinai Health System - The Canadian Open Genetics Repository (COGR)

See additional submitters

no assertion criteria provided
Benignunknownclinical testing

SCV001799646Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) - VKGL Data-share Consensus
no assertion criteria provided
Benigngermlineclinical testing

SCV001905791Clinical Genetics Laboratory, Department of Pathology, Netherlands Cancer Institute - VKGL Data-share Consensus

See additional submitters

no assertion criteria provided
Benigngermlineclinical testing

SCV002568042Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely benign
(Aug 15, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedunknownyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A systematic approach to assessing the clinical significance of genetic variants.

Duzkale H, Shen J, McLaughlin H, Alfares A, Kelly MA, Pugh TJ, Funke BH, Rehm HL, Lebo MS.

Clin Genet. 2013 Nov;84(5):453-63. doi: 10.1111/cge.12257.

PubMed [citation]
PMID:
24033266
PMCID:
PMC3995020

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV000540065.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Department of Pathology and Laboratory Medicine, Sinai Health System - The Canadian Open Genetics Repository (COGR), SCV001553089.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

GnomAD population frequency 44%

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyesnot providednot providednot providednot providednot providednot providednot provided

From Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) - VKGL Data-share Consensus, SCV001799646.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Clinical Genetics Laboratory, Department of Pathology, Netherlands Cancer Institute - VKGL Data-share Consensus, SCV001905791.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, SCV002568042.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024